Morgan Stanley »

Galectin Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $514k 227k 2.26
2024-03-31 $441k 185k 2.39
2023-12-31 $307k 185k 1.66
2023-09-30 $355k 185k 1.92
2023-06-30 $266k 185k 1.44
2022-12-31 $39k 39k 1.00
2022-06-30 $77k 59k 1.30
2022-03-31 $96k 64k 1.51
2021-06-30 $120k 41k 2.95
2020-12-31 $121k 54k 2.25
2020-09-30 $87k 32k 2.76
2020-06-30 $199k 65k 3.05
2020-03-31 $110k 56k 1.99
2019-12-31 $468k 164k 2.86
2019-09-30 $283k 77k 3.66
2019-03-31 $299k 59k 5.07
2018-12-31 $213k 62k 3.43
2018-09-30 $342k 58k 5.92
2018-06-30 $391k 61k 6.37
2018-03-31 $210k 44k 4.75
2017-12-31 $53k 16k 3.30
2017-03-31 $206k 90k 2.30
2016-12-31 $6.7k 6.5k 1.03
2016-09-30 $6.3k 6.6k 0.95
2016-06-30 $11k 8.1k 1.35
2016-03-31 $0 5.9k 0.00
2015-12-31 $15k 11k 1.47
2015-09-30 $34k 14k 2.39
2015-06-30 $74k 27k 2.71
2014-12-31 $346k 100k 3.45
2014-09-30 $130k 26k 5.01
2014-06-30 $1.2M 85k 13.83
2014-03-31 $1.4M 92k 15.30
2013-12-31 $149k 18k 8.42
2013-09-30 $146k 15k 9.96